ストックスクリーナーアプリを入手
15.29
0.52%
-0.08
プレマーケット:
15.29
前日終値:
$15.37
開ける：
$15.9
24時間の取引高:
2.75M
Relative Volume:
1.67
時価総額：
$1.36B
収益：
$-249.00K
当期純損益:
$-187.60M
株価収益率:
-6.116
EPS:
-2.5
ネットキャッシュフロー:
$-201.88M
1週間 パフォーマンス:
+7.75%
1か月 パフォーマンス:
+14.88%
6か月 パフォーマンス:
+261.47%
1年 パフォーマンス:
+228.11%
1日の値動き範囲:
$15.10
$16.96
1週間の範囲:
$13.99
$16.96
52週間の値動き範囲:
$2.865
$16.96
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
名前
Amylyx Pharmaceuticals Inc
セクター
電話
617-683-0917
住所
43 THORNDIKE STREET, CAMBRIDGE
AMLX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals Inc
|
15.29 | 1.64B | -249.00K | -187.60M | -201.88M | -2.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.00 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.34 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.75 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.31 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Goldman | Buy |
| 2025-06-24 | 開始されました | Guggenheim | Buy |
| 2025-06-17 | 開始されました | Citigroup | Buy |
| 2025-05-30 | 開始されました | TD Cowen | Buy |
| 2025-04-07 | アップグレード | Mizuho | Neutral → Outperform |
| 2024-11-18 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-10-23 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-03-18 | ダウングレード | Mizuho | Buy → Neutral |
| 2024-03-11 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-11 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-03-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-03-08 | ダウングレード | Goldman | Buy → Neutral |
| 2024-01-03 | 開始されました | Robert W. Baird | Outperform |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-07-24 | アップグレード | Goldman | Neutral → Buy |
| 2023-03-31 | 開始されました | Mizuho | Buy |
| 2023-01-05 | 開始されました | BofA Securities | Buy |
| 2022-05-25 | 開始されました | Citigroup | Buy |
| 2022-04-01 | ダウングレード | Goldman | Buy → Neutral |
すべてを表示
Amylyx Pharmaceuticals Inc (AMLX) 最新ニュース
Trend analysis for Amylyx Pharmaceuticals Inc. this weekJuly 2025 Weekly Recap & Low Risk High Reward Trade Ideas - newser.com
Using economic indicators to assess Amylyx Pharmaceuticals Inc. potential2025 Volume Leaders & Daily Price Action Insights - newser.com
Tools to monitor Amylyx Pharmaceuticals Inc. recovery probabilityMarket Rally & Smart Money Movement Tracker - newser.com
Will Amylyx Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
Measuring Amylyx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Published on: 2025-10-20 22:38:43 - newser.com
What’s the recovery path for long term holders of Amylyx Pharmaceuticals Inc.2025 Market Overview & Weekly High Potential Stock Alerts - newser.com
Important Notice to Long-Term Shareholders of Amylyx - GlobeNewswire
Will Amylyx Pharmaceuticals Inc. stock deliver better than expected guidanceWeekly Trade Analysis & Consistent Income Trade Recommendations - newser.com
Using flow based indicators on Amylyx Pharmaceuticals Inc.Trade Analysis Report & Risk Managed Trade Strategies - newser.com
Why Amylyx Pharmaceuticals Inc. stock attracts global investorsWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com
How the Class Action Investigation Into Relyvrio Disclosures at Amylyx Pharmaceuticals (AMLX) Has Changed Its Investment Story - Sahm
How Amylyx Pharmaceuticals Inc. stock benefits from global expansionRecession Risk & Advanced Technical Signal Analysis - nchmf.gov.vn
Is Amylyx Pharmaceuticals Inc. stock attractive for long term wealth buildingPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com
How supply chain issues affect Amylyx Pharmaceuticals Inc. stockPortfolio Return Report & Scalable Portfolio Growth Methods - nchmf.gov.vn
Growth Value: Why Amylyx Pharmaceuticals Inc. stock attracts global investorsBull Run & High Yield Equity Trading Tips - nchmf.gov.vn
Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonInsider Buying & Expert Approved Momentum Ideas - nchmf.gov.vn
Aug Swings: Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Summary & Low Risk Profit Maximizing Plans - nchmf.gov.vn
Volatility Watch: Will Amylyx Pharmaceuticals Inc. stock beat EPS estimates2025 Technical Overview & Free Real-Time Market Sentiment Alerts - nchmf.gov.vn
Amylyx Pharmaceuticals (AMLX): Assessing Valuation After Class Action Probe Challenges Relyvrio Demand Claims - Sahm
Will Amylyx Pharmaceuticals Inc. stock beat EPS estimatesShort Setup & Weekly Top Performers Watchlists - nchmf.gov.vn
Exit Recap: Is Amylyx Pharmaceuticals Inc. stock affected by interest rate hikesGold Moves & Expert Curated Trade Setups - nchmf.gov.vn
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); ... - Bluefield Daily Telegraph
Oklahoma City NewsThe Oklahoman - FinancialContent
Is AMLX Stock a Solid Choice Right Now? - sharewise.com
AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
About Us - FinancialContent
Baird Maintains Amylyx Pharmaceuticals (AMLX) Outperform Recommendation - Nasdaq
How institutional ownership impacts Amylyx Pharmaceuticals Inc. stockWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Amylyx Pharmaceuticals prices $175M public offering - MSN
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
Will Amylyx Pharmaceuticals Inc. stock continue upward momentumMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
Amylyx Pharmaceuticals, Inc. Securities Lawsuit Investigation - Claim Depot
Published on: 2025-10-13 09:41:01 - newser.com
Amylyx Pharmaceuticals Q2 2025 Earnings Preview - MSN
Upcoming Events - FinancialContent
Amylyx Pharmaceuticals Inc (AMLX) 財務データ
収益
当期純利益
現金流量
EPS
2.32%
1.34%
大文字化:
|
ボリューム (24 時間):